Literature DB >> 1233078

Horizontal studies of cell mediated immune reactions to autologous tumour antigens in patients with operable mammary carcinoma.

B M Jones, A R Turnbull.   

Abstract

The leucocyte migration and guinea-pig macrophage migration procedures were used to assess cell mediated, tumour directed immune reactions in patients with mammary carcinoma undergoing simple mastectomy with or without post-operative irradiation. Forty-seven per cent of patients reacted to autologous tumour antigens and 40% to allogeneic antigens when tested 7 days after operation; 23% reacted to autologous antigens at 2 months, 19% at 6 months and 34% at 1 year after surgery. Reactions to benign tissue fractions were rare. Better discrimination between test and control subjects was obtained when 3000 g sediments rather than nuclei-depleted homogenates (extracts) were used. Irradiation 3-7 weeks post-operatively did not depress the in vitro response at 2 months and yielded a higher rate of positive reactions at 6 months. Correlations of serial LMT responses with certain clinical findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233078      PMCID: PMC2024748          DOI: 10.1038/bjc.1975.232

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Cellular responses to autologous breast cancer tissue. Sequential observations.

Authors:  M M Black; H P Leis
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

Review 2.  Sensitization to tumour-associated antigens in human breast carcinoma.

Authors:  A J Cochran; R M Grant; W G Spilg; R M Mackie; C E Ross; D E Hoyle; J M Russell
Journal:  Int J Cancer       Date:  1974-07-15       Impact factor: 7.396

3.  In vitro study of cellular immunity against autochthonous human cancer.

Authors:  A Segall; O Weiler; J Genin; J Lacour; F Lacour
Journal:  Int J Cancer       Date:  1972-03-15       Impact factor: 7.396

4.  Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma.

Authors:  J Stjernswärd; M Jondal; F Vánky; H Wigzell; R Sealy
Journal:  Lancet       Date:  1972-06-24       Impact factor: 79.321

5.  Cellular responses to autologous breast cancer tissue. Correlation with stage and lymphoreticuloendothelial reactive.

Authors:  M M Black; H P Leis
Journal:  Cancer       Date:  1971-08       Impact factor: 6.860

6.  Cellular immunity to human breast carcinoma.

Authors:  G Fossati; S Canevari; G Della Porta; G P Balzarini; U Veronesi
Journal:  Int J Cancer       Date:  1972-09-15       Impact factor: 7.396

7.  Effect of postoperative radiotherapy on peripheral blood lymphocytes in patients with carcinoma of the breast.

Authors:  J A McCredie; W R Inch; R M Sutherland
Journal:  Cancer       Date:  1972-02       Impact factor: 6.860

8.  Comparative effects of tumor extracts on lymphocyte transformation in peripheral blood cultures of healthy persons and patients with breast cancer.

Authors:  E Golob; P Fischer; H Holzner; E Kunze-Mühl
Journal:  Z Krebsforsch       Date:  1969

9.  Inhibition of migration of human autogenous and allogeneic leukocytes by extracts of patients' cancers.

Authors:  W H Wolberg
Journal:  Cancer Res       Date:  1971-06       Impact factor: 12.701

10.  Human breast carcinoma. 3. Cellular responses to autologous breast cancer: skin-window procedure.

Authors:  H P Leis; M M Black
Journal:  N Y State J Med       Date:  1970-10-15
View more
  4 in total

Review 1.  Serial immune function testing to predict clinical disease relapse in patients with solid tumors.

Authors:  D P Braun; J E Harris
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

2.  Mechanisms of leucocyte migration inhibition by breast tumour cell fractions.

Authors:  B M Jones
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

3.  Tumour-directed leucocyte migration inhibition in operable breast cancer: additional clinical correlations.

Authors:  B M Jones; C E Connolly; P Isaacson; D T Turner; A R Turnbull
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

4.  Serial immune testing in surgically resected lung cancer patients.

Authors:  D P Braun; S Nisius; A Hollinshead; J E Harris
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.